Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2.
Mantovani, G
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. [electronic resource] - Cancer immunology, immunotherapy : CII Nov 1998 - 149-56 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0340-7004
10.1007/s002620050515 doi
Adult
Aged
Antineoplastic Agents--adverse effects
Carcinoma, Squamous Cell--drug therapy
Cisplatin--adverse effects
Drug Therapy, Combination
Female
Fluorouracil--adverse effects
Head and Neck Neoplasms--drug therapy
Humans
Interleukin-2--adverse effects
Male
Middle Aged
Recombinant Proteins--adverse effects
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. [electronic resource] - Cancer immunology, immunotherapy : CII Nov 1998 - 149-56 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0340-7004
10.1007/s002620050515 doi
Adult
Aged
Antineoplastic Agents--adverse effects
Carcinoma, Squamous Cell--drug therapy
Cisplatin--adverse effects
Drug Therapy, Combination
Female
Fluorouracil--adverse effects
Head and Neck Neoplasms--drug therapy
Humans
Interleukin-2--adverse effects
Male
Middle Aged
Recombinant Proteins--adverse effects